Rhenman & Partners Asset Management AB
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Rhenman & Partners Asset Management AB reported 93 stock positions worth $1.0 billion. Its top holding was Unitedhealth (UNH) at 5.1% of the portfolio, followed by Elevance Health (ELV, 4.5%) and Boston Scientific (BSX, 4.4%). Compared with Q1 2024, it opened 14 new positions, sold out of 5, added to 36 and reduced 31. The biggest buy was Unitedhealth (UNH, shares +160%) and the biggest sale Cigna (CI, shares −46%).
- Most Recent 13F
- Q2 2026
- Location
- Stockholm, V7
- CIK
- 0001599882
- Portfolio Value
- $1.0B (Q2 2024)
- SEC Filing
- 0001213900-24-067896 ↗ filed Aug 13, 2024
Holdings Value
Holdings 93 stocks · $1.0B
| UNH Unitedhealth Group Inc. | 5.15% | 105,300 | $53.6M | Add +160.0% |
| ELV Elevance Health Inc. | 4.46% | 85,800 | $46.5M | Add +23.4% |
| BSX Boston Scientific Corp. | 4.40% | 595,000 | $45.8M | Add +2.2% |
| LLY Eli Lilly & Co. | 4.09% | 47,000 | $42.6M | Reduce -13.2% |
| REGN Regeneron Pharmaceuticals | 3.23% | 32,000 | $33.6M | Reduce -6.7% |
| ABBV Abbvie Inc. | 3.11% | 189,000 | $32.4M | Reduce -0.3% |
| THC Tenet Healthcare Corp. | 2.92% | 229,000 | $30.5M | Reduce -39.7% |
| OSCR Oscar Health Inc. Class A | 2.90% | 1,906,611 | $30.2M | Add +12.7% |
| COO The Cooper Cos Inc. | 2.60% | 310,000 | $27.1M | Add +3.0% |
| ISRG Intuitive Surgical Inc. | 2.58% | 60,500 | $26.9M | Add +19.8% |
| PRCT Procept Biorobotics Corp. | 2.58% | 440,000 | $26.9M | Reduce -9.7% |
| BDX Becton Dickinson and Co. | 2.54% | 113,000 | $26.4M | Reduce -2.6% |
| HCA HCA Healthcare Inc. | 2.53% | 82,000 | $26.3M | Reduce -18.0% |
| VRTX Vertex Pharmaceuticals Inc. | 2.43% | 54,000 | $25.3M | Reduce -4.4% |
| CI The Cigna Group | 2.35% | 74,171 | $24.5M | Reduce -45.9% |
| MRK Merck & Co. Inc. | 2.08% | 175,000 | $21.7M | Reduce -19.9% |
| ALNY Alnylam Pharmaceuticals Inc. | 1.99% | 85,500 | $20.8M | Add +102.1% |
| BMRN Biomarin Pharmaceutical Inc. | 1.99% | 251,500 | $20.7M | Add +5.9% |
| BIIB Biogen Inc. | 1.89% | 84,800 | $19.7M | Add +49.3% |
| MCK McKesson Corp. | 1.68% | 30,000 | $17.5M | Reduce -31.8% |
| NTRA Natera Inc. | 1.63% | 157,000 | $17.0M | Reduce -34.6% |
| MDT Medtronic PLC | 1.57% | 208,000 | $16.4M | Reduce -36.0% |
| GILD Gilead Sciences Inc. | 1.57% | 238,500 | $16.4M | Add +87.8% |
| ABT Abbott Laboratories | 1.45% | 145,000 | $15.1M | Reduce -21.6% |
| RPRX Royalty Pharma PLC Class A | 1.38% | 544,697 | $14.4M | No change |
| DVAX Dynavax Technologies Corp. | 1.33% | 1,232,361 | $13.8M | Add +6.5% |
| ALGN Align Technology Inc. | 1.31% | 56,500 | $13.6M | Add +13.0% |
| TMO Thermo Fisher Scientific Inc. | 1.27% | 24,000 | $13.3M | Add +84.6% |
| DXCM Dexcom Inc. | 1.27% | 117,000 | $13.3M | Reduce -15.5% |
| CNC Centene Corp. | 1.26% | 198,482 | $13.2M | Add +53.9% |
| ALHC Alignment Healthcare Inc. | 1.23% | 1,641,448 | $12.8M | Reduce -18.9% |
| JAZZ Jazz Pharmaceuticals PLC | 1.17% | 114,000 | $12.2M | Reduce -22.3% |
| DHR Danaher Corp. | 1.16% | 48,500 | $12.1M | Add +340.9% |
| COR Cencora Inc. | 1.11% | 51,500 | $11.6M | Add +21.2% |
| CYTK Cytokinetics Inc. | 1.03% | 197,515 | $10.7M | No change |
| NBIX Neurocrine Biosciences Inc. | 1.00% | 75,555 | $10.4M | Add +28.1% |
| AXSM Axsome Therapeutics Inc. | 0.99% | 127,600 | $10.3M | Reduce -11.1% |
| ITCI Intra-Cellular Therapies Inc. | 0.93% | 142,000 | $9.7M | Add +3.3% |
| PODD Insulet Corp. | 0.90% | 46,500 | $9.4M | Add +33.8% |
| EW Edwards Lifesciences Corp. | 0.86% | 97,500 | $9.0M | New |
| MDGL Madrigal Pharmaceuticals Inc. | 0.71% | 26,500 | $7.4M | Reduce -27.4% |
| IOVA Iovance Biotherapeutics Inc. | 0.71% | 920,000 | $7.4M | Reduce -3.7% |
| CRL Charles River Laboratories | 0.67% | 34,000 | $7.0M | Add +167.7% |
| INSM Insmed Inc. | 0.64% | 99,513 | $6.7M | New |
| IQV Iqvia Holdings Inc. | 0.63% | 31,000 | $6.6M | No change |
| NUVL Nuvalent Inc. Class A | 0.60% | 82,750 | $6.3M | Reduce -5.4% |
| IONS Ionis Pharmaceuticals Inc. | 0.59% | 130,000 | $6.2M | New |
| EXAS Exact Sciences Corp. | 0.59% | 145,000 | $6.1M | Add +1.4% |
| SYK Stryker Corp. | 0.59% | 18,000 | $6.1M | Add +125.0% |
| ARVN Arvinas Inc. | 0.59% | 230,000 | $6.1M | Add +35.3% |
| VKTX Viking Therapeutics Inc. | 0.59% | 115,000 | $6.1M | Reduce -20.7% |
| GKOS Glaukos Corp. | 0.57% | 50,000 | $5.9M | Add +85.2% |
| MRUS Merus NV | 0.51% | 90,500 | $5.4M | New |
| EHC Encompass Health Corp. | 0.49% | 60,000 | $5.1M | Add +106.9% |
| SNDX Syndax Pharmaceuticals Inc. | 0.45% | 228,500 | $4.7M | Add +28.0% |
| BBIO Bridgebio Pharma Inc. | 0.45% | 184,500 | $4.7M | Add +76.6% |
| MIRM Mirum Pharmaceuticals Inc. | 0.44% | 134,250 | $4.6M | Add +45.5% |
| JANX Janux Therapeutics Inc. | 0.43% | 106,847 | $4.5M | Add +2.3% |
| ANNX Annexon Inc. | 0.42% | 900,000 | $4.4M | New |
| ESPR Esperion Therapeutics Inc. | 0.42% | 1,975,000 | $4.4M | New |
| EPIX Essa Pharma Inc. | 0.41% | 806,054 | $4.2M | Reduce -11.6% |
| XNCR Xencor Inc. | 0.40% | 218,750 | $4.1M | No change |
| PEN Penumbra Inc. | 0.40% | 23,000 | $4.1M | Reduce -50.0% |
| TGTX TG Therapeutics Inc. | 0.36% | 213,500 | $3.8M | Add +72.9% |
| NRIX Nurix Therapeutics Inc. | 0.35% | 174,393 | $3.6M | New |
| ALKS Alkermes PLC | 0.35% | 150,000 | $3.6M | Add +36.4% |
| KRYS Krystal Biotech Inc. | 0.34% | 19,000 | $3.5M | No change |
| IMVT Immunovant Inc. | 0.33% | 130,500 | $3.4M | Add +4.0% |
| KURA Kura Oncology Inc. | 0.33% | 166,526 | $3.4M | No change |
| STAA Staar Surgical Co. | 0.30% | 65,000 | $3.1M | New |
| ACHC Acadia Healthcare Co. Inc. | 0.26% | 39,824 | $2.7M | Add +215.5% |
| INSP Inspire Medical Systems Inc. | 0.22% | 17,000 | $2.3M | Reduce -59.5% |
| APLS Apellis Pharmaceuticals Inc. | 0.20% | 55,395 | $2.1M | Reduce -69.0% |
| MOH Molina Healthcare Inc. | 0.20% | 7,000 | $2.1M | New |
| TMDX Transmedics Group Inc. | 0.20% | 13,500 | $2.0M | New |
| PRVA Privia Health Group Inc. | 0.19% | 114,000 | $2.0M | No change |
| IMCR Immunocore Holdings PLC-ADR | 0.19% | 58,278 | $2.0M | Reduce -26.9% |
| IDYA Ideaya Biosciences Inc. | 0.18% | 53,500 | $1.9M | New |
| RVNC Revance Therapeutics Inc. | 0.17% | 701,707 | $1.8M | No change |
| INMB Inmune Bio Inc. | 0.15% | 178,284 | $1.6M | No change |
| RLAY Relay Therapeutics Inc. | 0.14% | 230,000 | $1.5M | No change |
| TECH Bio-Techne Corp. | 0.14% | 20,000 | $1.4M | Add +25.0% |
| XENE Xenon Pharmaceuticals Inc. | 0.13% | 35,000 | $1.4M | New |
| IGMS Igm Biosciences Inc. | 0.13% | 195,000 | $1.3M | No change |
| AMGN Amgen Inc. | 0.13% | 4,250 | $1.3M | No change |
| PLRX Pliant Therapeutics Inc. | 0.12% | 120,250 | $1.3M | Reduce -17.2% |
| AVTR Avantor Inc. | 0.12% | 60,000 | $1.3M | Reduce -64.9% |
| RGEN Repligen Corp. | 0.12% | 10,000 | $1.3M | Add +100.0% |
| MEDP Medpace Holdings Inc. | 0.10% | 2,500 | $1.0M | New |
| NARI Inari Medical Inc. | 0.09% | 20,000 | $963K | Reduce -64.5% |
| EVH Evolent Health Inc. Class A | 0.09% | 50,000 | $956K | New |
| AUGX Augmedix Inc. | 0.08% | 1,000,000 | $880K | Add +25.0% |
| BRKR Bruker Corp. | 0.04% | 6,000 | $383K | Reduce -70.0% |
Portfolio Sells Q1 2024 → Q2 2024
| CI The Cigna Group | Reduce -45.9% | 2.35% | −2.37 |
| SWAV Shockwave Medical Inc. | Sold out | 0.00% | −1.98 |
| MDT Medtronic PLC | Reduce -36.0% | 1.57% | −1.11 |
| THC Tenet Healthcare Corp. | Reduce -39.7% | 2.92% | −0.86 |
| ZBH Zimmer Biomet Holdings Inc. | Sold out | 0.00% | −0.84 |
| APLS Apellis Pharmaceuticals Inc. | Reduce -69.0% | 0.20% | −0.79 |
| NVCR Novocure Ltd. | Sold out | 0.00% | −0.73 |
| MRK Merck & Co. Inc. | Reduce -19.9% | 2.08% | −0.65 |
| INSP Inspire Medical Systems Inc. | Reduce -59.5% | 0.22% | −0.64 |
| IOVA Iovance Biotherapeutics Inc. | Reduce -3.7% | 0.71% | −0.63 |
| HCA HCA Healthcare Inc. | Reduce -18.0% | 2.53% | −0.63 |
| PEN Penumbra Inc. | Reduce -50.0% | 0.40% | −0.58 |
| MCK McKesson Corp. | Reduce -31.8% | 1.68% | −0.56 |
| DXCM Dexcom Inc. | Reduce -15.5% | 1.27% | −0.55 |
| ABT Abbott Laboratories | Reduce -21.6% | 1.45% | −0.55 |
| VKTX Viking Therapeutics Inc. | Reduce -20.7% | 0.59% | −0.54 |
| JAZZ Jazz Pharmaceuticals PLC | Reduce -22.3% | 1.17% | −0.51 |
| NTRA Natera Inc. | Reduce -34.6% | 1.63% | −0.45 |
| EPIX Essa Pharma Inc. | Reduce -11.6% | 0.41% | −0.33 |
| ALPN Alpine Immune Sciences Inc. | Sold out | 0.00% | −0.32 |
| IMCR Immunocore Holdings PLC-ADR | Reduce -26.9% | 0.19% | −0.30 |
| AVTR Avantor Inc. | Reduce -64.9% | 0.12% | −0.29 |
| MDGL Madrigal Pharmaceuticals Inc. | Reduce -27.4% | 0.71% | −0.21 |
| BDX Becton Dickinson and Co. | Reduce -2.6% | 2.54% | −0.19 |
| NARI Inari Medical Inc. | Reduce -64.5% | 0.09% | −0.16 |
| ABBV Abbvie Inc. | Reduce -0.3% | 3.11% | −0.16 |
| BRKR Bruker Corp. | Reduce -70.0% | 0.04% | −0.14 |
| NTLA Intellia Therapeutics Inc. | Sold out | 0.00% | −0.13 |
| AXSM Axsome Therapeutics Inc. | Reduce -11.1% | 0.99% | −0.10 |
| PLRX Pliant Therapeutics Inc. | Reduce -17.2% | 0.12% | −0.08 |
| NUVL Nuvalent Inc. Class A | Reduce -5.4% | 0.60% | −0.02 |
| LLY Eli Lilly & Co. | Reduce -13.2% | 4.09% | +0.09 |
| REGN Regeneron Pharmaceuticals | Reduce -6.7% | 3.23% | +0.10 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -4.4% | 2.43% | +0.19 |
| ALHC Alignment Healthcare Inc. | Reduce -18.9% | 1.23% | +0.28 |
| PRCT Procept Biorobotics Corp. | Reduce -9.7% | 2.58% | +0.30 |
Portfolio Buys Q1 2024 → Q2 2024
| UNH Unitedhealth Group Inc. | Add +160.0% | 5.15% | +3.25 |
| ALNY Alnylam Pharmaceuticals Inc. | Add +102.1% | 1.99% | +1.40 |
| ELV Elevance Health Inc. | Add +23.4% | 4.46% | +1.05 |
| DHR Danaher Corp. | Add +340.9% | 1.16% | +0.90 |
| EW Edwards Lifesciences Corp. | New | 0.86% | +0.86 |
| BIIB Biogen Inc. | Add +49.3% | 1.89% | +0.73 |
| GILD Gilead Sciences Inc. | Add +87.8% | 1.57% | +0.69 |
| ISRG Intuitive Surgical Inc. | Add +19.8% | 2.58% | +0.67 |
| INSM Insmed Inc. | New | 0.64% | +0.64 |
| BSX Boston Scientific Corp. | Add +2.2% | 4.40% | +0.62 |
| IONS Ionis Pharmaceuticals Inc. | New | 0.59% | +0.59 |
| TMO Thermo Fisher Scientific Inc. | Add +84.6% | 1.27% | +0.56 |
| MRUS Merus NV | New | 0.51% | +0.51 |
| OSCR Oscar Health Inc. Class A | Add +12.7% | 2.90% | +0.51 |
| ANNX Annexon Inc. | New | 0.42% | +0.42 |
| ESPR Esperion Therapeutics Inc. | New | 0.42% | +0.42 |
| NRIX Nurix Therapeutics Inc. | New | 0.35% | +0.35 |
| CRL Charles River Laboratories | Add +167.7% | 0.67% | +0.35 |
| PODD Insulet Corp. | Add +33.8% | 0.90% | +0.34 |
| GKOS Glaukos Corp. | Add +85.2% | 0.57% | +0.33 |
| SYK Stryker Corp. | Add +125.0% | 0.59% | +0.32 |
| CNC Centene Corp. | Add +53.9% | 1.26% | +0.30 |
| STAA Staar Surgical Co. | New | 0.30% | +0.30 |
| EHC Encompass Health Corp. | Add +106.9% | 0.49% | +0.27 |
| NBIX Neurocrine Biosciences Inc. | Add +28.1% | 1.00% | +0.23 |
| MIRM Mirum Pharmaceuticals Inc. | Add +45.5% | 0.44% | +0.22 |
| MOH Molina Healthcare Inc. | New | 0.20% | +0.20 |
| TMDX Transmedics Group Inc. | New | 0.20% | +0.20 |
| TGTX TG Therapeutics Inc. | Add +72.9% | 0.36% | +0.19 |
| IDYA Ideaya Biosciences Inc. | New | 0.18% | +0.18 |
| ACHC Acadia Healthcare Co. Inc. | Add +215.5% | 0.26% | +0.16 |
| BBIO Bridgebio Pharma Inc. | Add +76.6% | 0.45% | +0.14 |
| COR Cencora Inc. | Add +21.2% | 1.11% | +0.14 |
| XENE Xenon Pharmaceuticals Inc. | New | 0.13% | +0.13 |
| MEDP Medpace Holdings Inc. | New | 0.10% | +0.10 |
| EVH Evolent Health Inc. Class A | New | 0.09% | +0.09 |
| ALKS Alkermes PLC | Add +36.4% | 0.35% | +0.06 |
| JANX Janux Therapeutics Inc. | Add +2.3% | 0.43% | +0.06 |
| SNDX Syndax Pharmaceuticals Inc. | Add +28.0% | 0.45% | +0.05 |
| RGEN Repligen Corp. | Add +100.0% | 0.12% | +0.03 |
| ITCI Intra-Cellular Therapies Inc. | Add +3.3% | 0.93% | +0.03 |
| TECH Bio-Techne Corp. | Add +25.0% | 0.14% | +0.03 |
| BMRN Biomarin Pharmaceutical Inc. | Add +5.9% | 1.99% | +0.02 |
| DVAX Dynavax Technologies Corp. | Add +6.5% | 1.33% | −0.03 |
| IMVT Immunovant Inc. | Add +4.0% | 0.33% | −0.05 |
| ARVN Arvinas Inc. | Add +35.3% | 0.59% | −0.08 |
| AUGX Augmedix Inc. | Add +25.0% | 0.08% | −0.23 |
| ALGN Align Technology Inc. | Add +13.0% | 1.31% | −0.24 |
| COO The Cooper Cos Inc. | Add +3.0% | 2.60% | −0.30 |
| EXAS Exact Sciences Corp. | Add +1.4% | 0.59% | −0.35 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 99 | $1.1B | UNH, CVS, AZN, MRK, LLY |
| Q1 2026 | 86 | $810.5M | BSX, REGN, LLY, INSM, CVS |
| Q4 2025 | 94 | $1.1B | REGN, LLY, BSX, MDT, ISRG |
| Q3 2025 | 92 | $903.7M | BSX, LLY, ABBV, DHR, ALHC |
| Q2 2025 | 90 | $791.0M | LLY, BSX, VRTX, GKOS, ISRG |
| Q1 2025 | 94 | $870.0M | UNH, LLY, VRTX, MCK, BSX |
| Q4 2024 | 92 | $972.9M | BSX, LLY, PRCT, ISRG, REGN |
| Q3 2024 | 95 | $1.2B | BSX, UNH, LLY, REGN, THC |
| Q2 2024 | 93 | $1.0B | UNH, ELV, BSX, LLY, REGN |
| Q1 2024 | 84 | $1.1B | CI, LLY, THC, BSX, ELV |